QIAGEN Sciences, LLC, QIAGEN LLC, formerly known as QIAGEN Inc., QIAGEN GmbH & QIAGEN N.V, Defendants, represented by David Ellis Moore , Potter Anderson & Corroon, LLP, Anne S. Toker , Quinn Emanuel Urquhart & Sullivan, LLP, pro hac vice, Bindu Ann George Palapura , Potter Anderson & Corroon, LLP, David L. Bilsker , Quinn Emanuel Urquhart & Sullivan, LLP, pro hac vice, James E. Baker , Quinn Emanuel Urquhart & Sullivan, LLP, pro hac vice & Stephanie E. O'Byrne , Potter Anderson & Corroon, LLP.
As announced at the hearing on November 12, 20191, IT IS HEREBY ORDERED that the disputed claim terms of U.S. Patent No. 10,017,810 ("the '810 Patent") are construed as follows:<...
Let's get started
Welcome to the leading source of independent legal reporting Sign on now to see your case. Or view more than 10 million decisions and orders.
Updated daily.
Uncompromising quality.
Complete, Accurate, Current.
Listed below are the cases that are cited in this Featured Case. Click the citation to see the full
text of the cited case. Citations are also linked in the body of the Featured Case.
Cited Cases
No Cases Found
Listed below are those cases in which this Featured Case is cited. Click on the case name to see the
full text of the citing case.